Search research articles
Contact Us
Filters
Showing results (191-200 of 207) with videos related to
Page
of 21
Sort By:
The Journal of Clinical Investigation
|
December 31, 1997
Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively
A B van't Wout, L J Ran, M D de Jong, et al.
HIV Medicine
|
March 12, 2004
Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy
F van Leth, F W N M Wit, P Reiss, et al.
The Journal of Infectious Diseases
|
March 5, 2004
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
E Fontas, F van Leth, C A Sabin, et al.
HIV Medicine
|
April 25, 2006
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study
M G Law, N Friis-Møller, W M El-Sadr, et al.
Physical Review Letters
|
October 18, 2024
Unconventional Crystal Structure of the High-Pressure Superconductor La_{3}Ni_{2}O_{7}
P Puphal, P Reiss, N Enderlein, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
September 6, 2001
[HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy]
M Jambroes, G J Weverling, P Reiss, et al.
Lancet (London, England)
|
September 6, 2003
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies
G Chêne, J A C Sterne, M May, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 10, 2001
A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacy
D M Burger, P W Hugen, R E Aarnoutse, et al.
HIV Medicine
|
August 9, 2011
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients
S M E Vrouenraets, F W N M Wit, E Fernandez Garcia, et al.
HIV Medicine
|
February 2, 2018
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe
J R Santos, A Cozzi-Lepri, A Phillips, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 207) with videos related to
Sort By:
Page
of 21
The Journal of Clinical Investigation
|
December 31, 1997
Selective inhibition of syncytium-inducing and nonsyncytium-inducing HIV-1 variants in individuals receiving didanosine or zidovudine, respectively
A B van't Wout, L J Ran, M D de Jong, et al.
HIV Medicine
|
March 12, 2004
Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapy
F van Leth, F W N M Wit, P Reiss, et al.
The Journal of Infectious Diseases
|
March 5, 2004
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
E Fontas, F van Leth, C A Sabin, et al.
HIV Medicine
|
April 25, 2006
The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study
M G Law, N Friis-Møller, W M El-Sadr, et al.
Physical Review Letters
|
October 18, 2024
Unconventional Crystal Structure of the High-Pressure Superconductor La_{3}Ni_{2}O_{7}
P Puphal, P Reiss, N Enderlein, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
September 6, 2001
[HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy]
M Jambroes, G J Weverling, P Reiss, et al.
Lancet (London, England)
|
September 6, 2003
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies
G Chêne, J A C Sterne, M May, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
March 10, 2001
A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacy
D M Burger, P W Hugen, R E Aarnoutse, et al.
HIV Medicine
|
August 9, 2011
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patients
S M E Vrouenraets, F W N M Wit, E Fernandez Garcia, et al.
HIV Medicine
|
February 2, 2018
Long-term effectiveness of recommended boosted protease inhibitor-based antiretroviral therapy in Europe
J R Santos, A Cozzi-Lepri, A Phillips, et al.
Page
of 21